Questions: Metabotropic Glutamate Receptors

Question 1

A pharmacologist applies a drug that blocks all mGluRs at a synapse. Fast excitatory postsynaptic potentials (EPSPs) in response to single presynaptic spikes are completely unaffected. Why?

• A. mGluRs are redundant with AMPARs — blocking one has no effect while the other compensates
• B. Fast EPSPs are generated by ionotropic receptors (AMPARs) that open ion channels directly; mGluRs activate G-protein cascades and do not contribute to millisecond-scale voltage changes from single events
• C. mGluRs are located too far from the synapse to respond to glutamate from a single spike
• D. Blocking mGluRs upregulates AMPAR expression, compensating for the lost mGluR contribution

Answer: (B)

This result is expected from the functional distinction between ionotropic and metabotropic receptors. AMPARs are ligand-gated ion channels — glutamate binding directly opens a channel, producing a fast electrical response in milliseconds. mGluRs are GPCRs that activate intracellular second messenger cascades (PLC, adenylyl cyclase) on a timescale of seconds to minutes — far too slow to contribute to fast EPSPs from single spikes. They modulate synaptic gain over longer timescales. Option A is the classic misconception: mGluRs are not slower AMPARs — they are a qualitatively different signaling system that operates on different timescales and through different mechanisms.

Question 2

Which mGluR group functions as a presynaptic autoreceptor, and what is the net effect of its activation on neurotransmitter release?

• A. Group I (mGluR1/5); Gq coupling → PLC activation → increased Ca²+ → enhanced release
• B. Group II or III (mGluR2-4, 6-8); Gi/Go coupling → inhibit adenylyl cyclase and Ca²+ channels → reduced glutamate release
• C. Group II (mGluR2/3); Gs coupling → increase cAMP → enhanced vesicle fusion
• D. Group III (mGluR6-8); Gq coupling → IP3-mediated Ca²+ release → burst firing

Answer: (B)

Groups II and III mGluRs are typically presynaptic autoreceptors — they sense accumulating glutamate in or around the cleft and feed back to reduce further release. Their Gi/Go coupling inhibits adenylyl cyclase (reducing cAMP) and modulates Gβγ-gated K+ channels and voltage-gated Ca²+ channels, reducing presynaptic Ca²+ influx needed for vesicle fusion. This is an elegant negative-feedback safety valve: too much glutamate activates these receptors and dials release back down. Group I mGluRs (Gq, postsynaptic, excitatory) have the opposite profile — they are activated by spillover glutamate and amplify postsynaptic responsiveness, not suppress it.

Question 3

Metabotropic glutamate receptors are simply slower versions of AMPA receptors — both respond to glutamate by opening cation channels, but mGluRs do so over a longer time window.

• T. True
• F. False

Answer: False

mGluRs and AMPARs are categorically different in mechanism, not just speed. AMPARs are ionotropic — they ARE ion channels, and glutamate binding directly gates them. mGluRs are GPCRs — they have no channel pore at all. When glutamate binds an mGluR, it triggers a conformational change that activates a coupled G-protein (Gq or Gi/Go), initiating a second messenger cascade: PLC activation and IP3/DAG production (Group I), or adenylyl cyclase inhibition and cAMP reduction (Groups II/III). These cascades modulate ion channels and protein kinases indirectly. The result is not a fast current but a slower, longer-lasting change in synaptic gain, neuronal excitability, or gene expression.

Question 4

Group I mGluRs are typically postsynaptic, activate Gq protein, and can trigger calcium release from intracellular stores via the IP3 pathway.

• T. True
• F. False

Answer: True

Group I mGluRs (mGluR1 and mGluR5) are positioned perisynaptically on the postsynaptic side, where they detect glutamate spillover during sustained high-frequency synaptic activity. Their Gq coupling activates phospholipase C (PLC), which cleaves PIP2 into IP3 and diacylglycerol (DAG). IP3 binds receptors on the endoplasmic reticulum and triggers Ca²+ release into the cytoplasm; DAG activates protein kinase C. The net effect is enhanced postsynaptic responsiveness and amplification of ongoing synaptic transmission — in contrast to the inhibitory presynaptic feedback of Groups II/III. This postsynaptic excitatory role is also why mGluR5 is implicated in Fragile X syndrome.

Question 5

Explain why mGluR5 antagonists are being explored as treatments for Fragile X syndrome — trace the causal chain from the genetic defect to the mGluR-dependent problem.

Model answer: Fragile X syndrome is caused by silencing of the FMR1 gene, which encodes FMRP (Fragile X Mental Retardation Protein). FMRP normally acts as a translational repressor at synapses — it suppresses local protein synthesis in dendritic spines until synaptic activity calls for it. Without FMRP, proteins required for synaptic strengthening and remodeling are synthesized at excessive rates in response to synaptic activity. Group I mGluR activation (especially mGluR5) is a key trigger for this local protein synthesis: normally, mGluR5 stimulation induces a brief burst of dendritic protein synthesis that drives mGluR-LTD. In Fragile X, the translational brake is absent, so mGluR5 stimulation drives exaggerated protein synthesis and excessive LTD. Blocking mGluR5 reduces this excessive synthesis, potentially restoring the normal balance between LTP and LTD and rescuing synaptic and cognitive phenotypes.

The mGluR theory of Fragile X (proposed by Bear, Huber, and Warren) proposes that FMRP normally serves as a negative regulator that opposes mGluR5-dependent protein synthesis. Without it, mGluR5 signaling is effectively hyperactive. This predicts that reducing mGluR5 activity (with antagonists) should compensate for the loss of FMRP. Animal model studies broadly support this — mGluR5 antagonists rescue dendritic spine morphology, LTD magnitude, and behavioral phenotypes in Fmr1 knockout mice. Human trials have shown mixed results, possibly because the intervention window and appropriate outcome measures are still being refined.